Home › Mild Cognitive Impairment › Massachusetts › Newton
Mild Cognitive Impairment clinical trials in Newton, MA
4 studies for Mild Cognitive Impairment are looking for participants at sites in and around Newton (within about 30 miles). Open a study to see who can join and how to contact the study team.
A Study of Zunveyl on Safety, Tolerability, Neuropsychiatric Symptoms, and Caregiver Distress in Alzheimer's Disease (RESOLVE)
RecruitingPhase 4
- Adams Clinical - Watertown, Watertown · 3 mi away
Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies
RecruitingPhase 3
- Boston Center for Memory, Newton
- Adams Clinical Watertown, Watertown · 3 mi away
A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease (MINDSET 2)
RecruitingPhase 3
- Local Institution - 0080, Watertown · 3 mi away
A Study to Evaluate the Efficacy and Safety of KarXT + KarX-EC for Cognitive Impairment in Alzheimer's Disease
RecruitingPhase 3
- Boston Center for Memory, Newton
About Mild Cognitive Impairment
In mild cognitive impairment (MCI), you have more memory and thinking problems than others your age, but they don't interfere with your everyday life.
More about Mild Cognitive Impairment on MedlinePlus
Mild Cognitive Impairment trials in other cities
- New York City, NY23 studies
- Boston, MA21 studies
- Chicago, IL17 studies
- Baltimore, MD16 studies
- Los Angeles, CA12 studies
- Miami, FL11 studies
- Philadelphia, PA11 studies
- Birmingham, AL11 studies
- San Francisco, CA10 studies
- Houston, TX10 studies
- Durham, NC9 studies
- Washington, DC9 studies
Other studies in Newton
- Alzheimer's Disease12 studies
- Obesity10 studies
- Major Depressive Disorder9 studies
- Psoriasis6 studies
- Depression6 studies
- Overweight6 studies
- Non-Small Cell Lung Cancer5 studies
- Cancer (all types)4 studies
- Atopic Dermatitis (Eczema)4 studies
- Breast Cancer4 studies
- Ulcerative Colitis4 studies
- Schizophrenia4 studies
From ClinicalTrials.gov, data retrieved Oct 1, 2026. Each study sets its own eligibility; the study team decides who can join.